Bawei Chenxiang Wan (BCW), a well-known traditional Chinese Tibetan medicine formula,
is effective for the treatment of acute and chronic cardiovascular diseases. In the present …

Abstract Background Bawei Chenxiang Wan (BCW) is among the most effective and widely
used therapies for coronary heart disease and angina pectoris in Tibet. However, whether it …

Cardiac hypertrophy (CH) is a major risk factor for many serious heart diseases. Sustained
CH is catastrophic, resulting in cardiac dysfunction that eventually leads to heart failure (HF) …

Cardiac hypertrophy is a well‐established risk factor for cardiovascular mortality worldwide.
According to a recent study, hypoxia‐induced endoplasmic reticulum stress regulating long …

BACKGROUND Pathological cardiac hypertrophy is a compensated response to various
stimuli and is considered a key risk factor for heart failure. 7, 8-Dihydroxyflavone (7, 8-DHF) …

Heart failure is one of the leading causes of mortality not only in the Western world but also
in China. The key pathophysiological process that ultimately leads to heart failure is cardiac …

Cardiac hypertrophy is a common adaptive response to a variety of stimuli, but prolonged
hypertrophy leads to heart failure. Hence, discovery of agents treating cardiac hypertrophy is …

Atorvastatin is employed as a lipid lowering agent and its heart protective effect has been
recently reported as well. However, the mechanism of atorvastatin in attenuating cardiac …

Purpose Schisandra is a well-known traditional Chinese medicine in East Asia. As a
traditional Chinese medicine derivative with Schisandra chinensis as raw material, bicyclol …

Pathological cardiac hypertrophy is associated with adverse cardiovascular events and can
gradually lead to heart failure, arrhythmia, and even sudden death. However, the current …